Fingerprint
Dive into the research topics of 'Two year save outcomes: 2.0 mg Ranibizumab for Recalcitrant Neovascular AMD'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Two year save outcomes: 2.0 mg Ranibizumab for Recalcitrant Neovascular AMD
Charles C. Wykoff, David M. Brown, Daniel E. Croft, Tien P. Wong
Research output: Contribution to journal › Letter › peer-review
15
Scopus
citations